Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Higgins

Showing results (171-180 of 1,694) with videos related to

Pageof 170
Sort By:
Calcified Tissue International|September 1, 1992
Menopausal bone loss is partially regulated by dietary intake of vitamin DB Lukert, J Higgins, M Stoskopf
Journal of Human Hypertension|June 1, 1989
Clinical experience with lisinopril. Observations on safety and tolerabilityH A Cameron, T J Higgins
Expert Review of Anticancer Therapy|August 13, 2009
Expanding role of bisphosphonates in the management of early breast cancerMichaela J Higgins, Ben H Park
Cellular Immunology|November 1, 1976
Effect of isoproterernol and aminiphylline on cyclic AMP levels of guinea pig macrophagesT J Higgins, J R David
Anaesthesia|August 24, 2005
Dolasetron and peri-operative cardiac arrhythmiaD J Higgins, N J Bunker
Experimental Cell Research|July 1, 1992
Cell shape changes during transition of basal keratinocytes to mature enucleate-cornified envelopes: modulation of terminal differentiation by fibronectinL Staiano-Coico, P J Higgins
The Biochemical Journal|June 1, 1992
Identification of the 52 kDa cytoskeletal-like protein of cytochalasin D-stimulated normal rat kidney (NRK/CD) cells as substrate-associated glycoprotein p52 [plasminogen-activator inhibitor type-1 (PAI-1)]. Expression of p52 (PAI-1) in NRK/CD cells is regulated at the level of mRNA abundanceP J Higgins, M P Ryan
Current Oncology Reports|December 17, 2008
What is the current status of ovarian suppression/ablation in women with premenopausal early-stage breast cancer?Michaela J Higgins, Nancy E Davidson
Oncology (Williston Park, N.Y.)|March 17, 2009
Adjuvant endocrine therapy for premenopausal hormone receptor-positive breast cancer; much done, more to doMichaela J Higgins, Antonio C Wolf
Molecular Medicine & Therapeutics|August 13, 2013
Low Molecular Weight Antagonists of Plasminogen Activator Inhibitor-1: Therapeutic Potential in Cardiovascular DiseaseTessa M Simone, Paul J Higgins
Pageof 170

Showing results (171-180 of 1,694) with videos related to

Sort By:
Pageof 170
Calcified Tissue International|September 1, 1992
Menopausal bone loss is partially regulated by dietary intake of vitamin DB Lukert, J Higgins, M Stoskopf
Journal of Human Hypertension|June 1, 1989
Clinical experience with lisinopril. Observations on safety and tolerabilityH A Cameron, T J Higgins
Expert Review of Anticancer Therapy|August 13, 2009
Expanding role of bisphosphonates in the management of early breast cancerMichaela J Higgins, Ben H Park
Cellular Immunology|November 1, 1976
Effect of isoproterernol and aminiphylline on cyclic AMP levels of guinea pig macrophagesT J Higgins, J R David
Anaesthesia|August 24, 2005
Dolasetron and peri-operative cardiac arrhythmiaD J Higgins, N J Bunker
Experimental Cell Research|July 1, 1992
Cell shape changes during transition of basal keratinocytes to mature enucleate-cornified envelopes: modulation of terminal differentiation by fibronectinL Staiano-Coico, P J Higgins
The Biochemical Journal|June 1, 1992
Identification of the 52 kDa cytoskeletal-like protein of cytochalasin D-stimulated normal rat kidney (NRK/CD) cells as substrate-associated glycoprotein p52 [plasminogen-activator inhibitor type-1 (PAI-1)]. Expression of p52 (PAI-1) in NRK/CD cells is regulated at the level of mRNA abundanceP J Higgins, M P Ryan
Current Oncology Reports|December 17, 2008
What is the current status of ovarian suppression/ablation in women with premenopausal early-stage breast cancer?Michaela J Higgins, Nancy E Davidson
Oncology (Williston Park, N.Y.)|March 17, 2009
Adjuvant endocrine therapy for premenopausal hormone receptor-positive breast cancer; much done, more to doMichaela J Higgins, Antonio C Wolf
Molecular Medicine & Therapeutics|August 13, 2013
Low Molecular Weight Antagonists of Plasminogen Activator Inhibitor-1: Therapeutic Potential in Cardiovascular DiseaseTessa M Simone, Paul J Higgins
Pageof 170